Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07403032
Eligibility Criteria:
Inclusion Criteria:
1. Patients meeting diagnostic criteria for COPD exacerbation, as defined by "Expert consensus on the acute exacerbation of chronic obstructive pulmonary disease in China (revision in 2023)" ;
2. Patients meeting the diagnostic criteria for phlegm-heat stagnation in the lungs syndrome within COPD, as referenced in the "Clinical Diagnosis and Treatment Terminology of Traditional Chinese Medicine: Syndromes" and the 2020 International Guidelines for Clinical Practice of Traditional Chinese Medicine;
3. Age \> 18 years;
4. Hospitalized patients;
5. Voluntarily consent to treatment and sign an informed consent form.
Exclusion Criteria:
1. History of allergy to the study drug;
2. History of active liver disease;
3. Patients undergoing dialysis or with known moderate to severe renal impairment;
4. Suspected or confirmed active systemic infection;
5. Patients with host immune dysfunction, host immunodeficiency, or host immune reconstitution.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07403032
Study Brief:
Protocol Section:
NCT07403032